LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 243 filers reported holding LIGAND PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 4.76 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $12,367,428 | -19.4% | 206,399 | -3.0% | 0.53% | -8.6% |
| Q2 2023 | $15,345,331 | +3.3% | 212,834 | +5.4% | 0.58% | +10.5% |
| Q1 2023 | $14,858,605 | -40.8% | 201,993 | +24.2% | 0.53% | -11.4% |
| Q4 2021 | $25,116,000 | -14.0% | 162,608 | -22.5% | 0.59% | -15.4% |
| Q3 2021 | $29,215,000 | -73.0% | 209,695 | -80.7% | 0.70% | -77.8% |
| Q4 2020 | $108,228,000 | +20.6% | 1,088,265 | +15.6% | 3.16% | -15.8% |
| Q3 2020 | $89,724,000 | -7.6% | 941,295 | +8.4% | 3.75% | -7.6% |
| Q2 2020 | $97,129,000 | +36.0% | 868,385 | -11.6% | 4.06% | +15.5% |
| Q1 2020 | $71,415,000 | -25.6% | 982,049 | +6.7% | 3.51% | +20.0% |
| Q4 2019 | $95,946,000 | +7.9% | 919,994 | +3.0% | 2.93% | -0.3% |
| Q3 2019 | $88,924,000 | -13.1% | 893,351 | -0.4% | 2.94% | -12.1% |
| Q2 2019 | $102,348,000 | -7.7% | 896,609 | +1.6% | 3.34% | -9.4% |
| Q1 2019 | $110,941,000 | +61.4% | 882,515 | +74.2% | 3.69% | +45.7% |
| Q4 2018 | $68,728,000 | -18.4% | 506,472 | +50.7% | 2.53% | -4.4% |
| Q3 2018 | $84,239,000 | -4.4% | 336,008 | -21.0% | 2.65% | -8.0% |
| Q2 2018 | $88,097,000 | +21.4% | 425,237 | -3.2% | 2.88% | +6.8% |
| Q1 2018 | $72,561,000 | -19.0% | 439,335 | -32.9% | 2.69% | -23.4% |
| Q4 2017 | $89,599,000 | +5.6% | 654,346 | +5.0% | 3.52% | +0.2% |
| Q3 2017 | $84,868,000 | -12.8% | 623,341 | -22.2% | 3.51% | -8.9% |
| Q2 2017 | $97,295,000 | +16.2% | 801,442 | +1.3% | 3.85% | +13.4% |
| Q1 2017 | $83,737,000 | +7.4% | 791,167 | +3.1% | 3.40% | +1.4% |
| Q4 2016 | $77,984,000 | +13.4% | 767,485 | +13.9% | 3.35% | +5.0% |
| Q3 2016 | $68,773,000 | -13.8% | 673,850 | +0.8% | 3.19% | -19.2% |
| Q2 2016 | $79,761,000 | -11.3% | 668,739 | -20.4% | 3.95% | -21.3% |
| Q1 2016 | $89,923,000 | -2.7% | 839,691 | -1.5% | 5.02% | -6.0% |
| Q4 2015 | $92,380,000 | +22.7% | 852,053 | -3.1% | 5.34% | +13.5% |
| Q3 2015 | $75,308,000 | -25.8% | 879,249 | -12.6% | 4.70% | -12.6% |
| Q2 2015 | $101,451,000 | +26.2% | 1,005,458 | -3.6% | 5.38% | +21.4% |
| Q1 2015 | $80,413,000 | +53.3% | 1,042,829 | +5.8% | 4.44% | +45.8% |
| Q4 2014 | $52,454,000 | +19.2% | 985,795 | +5.2% | 3.04% | +11.4% |
| Q3 2014 | $44,021,000 | +24.4% | 936,825 | +64.9% | 2.73% | +42.8% |
| Q2 2014 | $35,393,000 | -10.4% | 568,199 | -3.2% | 1.91% | -7.6% |
| Q1 2014 | $39,502,000 | +29.4% | 587,214 | +1.2% | 2.07% | +26.8% |
| Q4 2013 | $30,520,000 | – | 580,224 | – | 1.63% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knott David M Jr | 115,000 | $12,937,000 | 4.12% |
| Stonepine Capital Management, LLC | 73,700 | $8,291,000 | 3.44% |
| VILLERE ST DENIS J & CO LLC | 510,843 | $57,464,000 | 3.41% |
| Chicago Capital, LLC | 491,717 | $55,313,000 | 2.38% |
| Orchard Capital Management, LLC | 73,596 | $8,279,000 | 2.35% |
| RICE HALL JAMES & ASSOCIATES, LLC | 344,969 | $38,806,000 | 1.55% |
| Smith, Graham & Co., Investment Advisors, LP | 86,834 | $9,768,000 | 1.02% |
| WOODSTOCK CORP | 64,050 | $7,205,000 | 0.84% |
| INVESTMENT MANAGEMENT OF VIRGINIA LLC | 37,246 | $4,190,000 | 0.74% |
| Stephens Investment Management Group LLC | 417,670 | $46,984,000 | 0.69% |